CDH17 is a downstream effector of HOXA13 in modulating the Wnt/beta-catenin signaling pathway in gastric cancer

Qu, LP; Zhong, YM; Zheng, Z; Zhao, RX

Zhao, RX (reprint author), Weifang Peoples Hosp, Dept Gastroenterol, Weifang, Shandong, Peoples R China.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017; 21 (6): 1234